Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Pharmaceutical Statistics|November 8, 2014
Methods for exploring treatment effect heterogeneity in subgroup analysis: an application to global clinical trialsI Manjula Schou, Ian C MarschnerClinical Trials (London, England)|August 22, 2022
Analysis of adaptive platform trials using a network approachIan C Marschner, I Manjula SchouStatistical Methods in Medical Research|August 23, 2018
Underestimation of treatment effects in sequentially monitored clinical trials that did not stop early for benefitIan C Marschner, I Manjula SchouBiometrical Journal. Biometrische Zeitschrift|October 6, 2016
Design of clinical trials involving multiple hypothesis tests with a common controlI Manjula Schou, Ian C MarschnerBiometrical Journal. Biometrische Zeitschrift|August 6, 2024
Analysis of Nonconcurrent Controls in Adaptive Platform Trials: Separating Randomized and Nonrandomized InformationIan C Marschner, I Manjula SchouResearch Synthesis Methods|January 5, 2020
Sensitivity analyses assessing the impact of early stopping on systematic reviews: Recommendations for interpreting guidelinesIan C Marschner, Lisa M Askie, I Manjula SchouBJU International|November 5, 2025
Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancerYu Yang Soon, Ian C Marschner, I Manjula Schou, et al.JNCI Cancer Spectrum|June 2, 2025
INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner's curseYu Yang Soon, Katrin Sjoquist, Ian C Marschner, et al.Statistics in Medicine|January 11, 2024
Confidence distributions for treatment effects in clinical trials: Posteriors without priorsIan C MarschnerPharmaceutical Statistics|February 27, 2007
Optimal design of clinical trials comparing several treatments with a controlIan C MarschnerPageof 6